262 related articles for article (PubMed ID: 26551348)
21. [Radiation therapy for the treatment of macroscopic canine anal gland tumors - a retrospective study].
Rohrer Bley C; Czichon F; Körner M; Staudinger C; Meier VS
Schweiz Arch Tierheilkd; 2022 Nov; 164(11):789-799. PubMed ID: 36325642
[TBL] [Abstract][Full Text] [Related]
22. A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol.
Baja AJ; Kelsey KL; Ruslander DM; Gieger TL; Nolan MW
Vet Comp Oncol; 2022 Sep; 20(3):623-631. PubMed ID: 35338766
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of toxicity of a chronic alternate day metronomic cyclophosphamide chemotherapy protocol in dogs with naturally occurring cancer.
Matsuyama A; Woods JP; Mutsaers AJ
Can Vet J; 2017 Jan; 58(1):51-55. PubMed ID: 28042155
[TBL] [Abstract][Full Text] [Related]
24. Metronomic chemotherapy.
Mutsaers AJ
Top Companion Anim Med; 2009 Aug; 24(3):137-43. PubMed ID: 19732732
[TBL] [Abstract][Full Text] [Related]
25. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
[TBL] [Abstract][Full Text] [Related]
26. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.
Polton G; Finotello R; Sabattini S; Rossi F; Laganga P; Vasconi ME; Barbanera A; Stiborova K; Rohrer Bley C; Marconato L
Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493
[TBL] [Abstract][Full Text] [Related]
27. [Role of radiotherapy in combined therapy of soft tissue sarcoma in children and adolescents].
Golubicić I; Nikitović M; Bokun J; Gavrilović D; Radosević-Jelić Lj
Srp Arh Celok Lek; 2000; 128(5-6):172-8. PubMed ID: 11089417
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ
J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429
[TBL] [Abstract][Full Text] [Related]
29. Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer-bearing dogs: a retrospective study.
Harper A; Blackwood L
J Small Anim Pract; 2017 Apr; 58(4):227-230. PubMed ID: 28133740
[TBL] [Abstract][Full Text] [Related]
30. Comparison of definitive-intent finely fractionated and palliative-intent coarsely fractionated radiotherapy as adjuvant treatment of feline microscopic injection-site sarcoma.
Rossi F; Marconato L; Sabattini S; Cancedda S; Laganga P; Leone VF; Rohrer Bley C
J Feline Med Surg; 2019 Feb; 21(2):65-72. PubMed ID: 29473768
[TBL] [Abstract][Full Text] [Related]
31. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987-1997).
Freeman KP; Hahn KA; Harris FD; King GK
J Vet Intern Med; 2003; 17(1):96-101. PubMed ID: 12564733
[TBL] [Abstract][Full Text] [Related]
32. SAFETY AND TOXICITY OF AN ACCELERATED COARSELY FRACTIONATED RADIATION PROTOCOL FOR TREATMENT OF APPENDICULAR OSTEOSARCOMA IN 14 DOGS: 10 GY × 2 FRACTIONS.
Pagano C; Boudreaux B; Shiomitsu K
Vet Radiol Ultrasound; 2016 Sep; 57(5):551-6. PubMed ID: 27374864
[TBL] [Abstract][Full Text] [Related]
33. Survival times for canine intranasal sarcomas treated with radiation therapy: 86 cases (1996-2011).
Sones E; Smith A; Schleis S; Brawner W; Almond G; Taylor K; Haney S; Wypij J; Keyerleber M; Arthur J; Hamilton T; Lawrence J; Gieger T; Sellon R; Wright Z
Vet Radiol Ultrasound; 2013; 54(2):194-201. PubMed ID: 23278974
[TBL] [Abstract][Full Text] [Related]
34. Single high-dose radiation therapy and liquid fiducial markers can be used in dogs with incompletely resected soft tissue sarcomas.
Ericksen T; Mauldin N; Dickinson R; Mauldin G
J Am Vet Med Assoc; 2023 Oct; 261(10):1-8. PubMed ID: 37437890
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).
Bergman NS; Urie BK; Pardo AD; Newman RG
J Am Vet Med Assoc; 2016 May; 248(10):1148-56. PubMed ID: 27135671
[TBL] [Abstract][Full Text] [Related]
36. Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
McChesney SL; Gillette EL; Dewhirst MW; Withrow SJ
Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1957-63. PubMed ID: 3021693
[TBL] [Abstract][Full Text] [Related]
37. Retrospective study of canine nasal tumor treated with hypofractionated radiotherapy.
Maruo T; Shida T; Fukuyama Y; Hosaka S; Noda M; Ito T; Sugiyama H; Ishikawa T; Madarame H
J Vet Med Sci; 2011 Feb; 73(2):193-7. PubMed ID: 20938105
[TBL] [Abstract][Full Text] [Related]
38. Results of radiation therapy for unresected soft-tissue sarcomas.
Kepka L; DeLaney TF; Suit HD; Goldberg SI
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):852-9. PubMed ID: 16199316
[TBL] [Abstract][Full Text] [Related]
39. Response of Canine Soft Tissue Sarcoma to Stereotactic Body Radiotherapy.
Tierce R; Martin T; Hughes KL; Harrison L; Swancutt KL; Rao S; Leary D; LaRue SM; Boss MK
Radiat Res; 2021 Dec; 196(6):587-601. PubMed ID: 34473832
[TBL] [Abstract][Full Text] [Related]
40. Canine soft tissue sarcoma managed in first opinion practice: outcome in 350 cases.
Bray JP; Polton GA; McSporran KD; Bridges J; Whitbread TM
Vet Surg; 2014 Oct; 43(7):774-82. PubMed ID: 24724565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
